Anlotinib Combined With Sintilimab as Third-line Treatment or Beyond in Patients With Small Cell Lung Cancer
Latest Information Update: 07 Jan 2022
At a glance
- Drugs Catequentinib (Primary) ; Sintilimab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Dec 2019 New trial record